Cigna Group (NYSE:CI) Upgraded to "Buy" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Cigna Group to “Buy” from “Hold.” The broader analyst consensus is “Moderate Buy,” with 15 Buy ratings and 7 Holds and an average price target of $339.45.
• Cigna reported quarterly earnings of $7.78 per share, beating estimates of $7.60, while revenue rose 6.7% year over year to $70.04 billion. The company reiterated fiscal 2026 earnings guidance of approximately $30.45 per share.
• Institutional investors own nearly 87% of Cigna’s shares, while insiders sold 23,012 shares worth $6.39 million over the past three months.

Cigna Group (NYSE:CI - Get Free Report) was upgraded by Wall Street Zen from a "hold" rating to a "buy" rating in a note issued to investors on Saturday.

Other research analysts have also recently issued reports about the stock. Mizuho raised their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research note on Monday, June 8th. Wells Fargo & Company upped their target price on Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. UBS Group increased their target price on Cigna Group from $375.00 to $400.00 and gave the company a "buy" rating in a report on Friday, May 22nd. Sanford C. Bernstein raised their price target on Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a research report on Thursday, July 9th. Finally, Deutsche Bank Aktiengesellschaft cut Cigna Group from a "buy" rating to a "hold" rating and cut their price target for the stock from $303.00 to $302.00 in a report on Wednesday, May 20th. Fifteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $339.45.

Cigna Group Price Performance

Shares of NYSE CI opened at $278.89 on Friday. The stock has a market cap of $73.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47. The company's 50-day moving average price is $283.52 and its 200 day moving average price is $281.39. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. During the same period last year, the firm posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.

Insider Activity at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of Cigna Group stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company's stock, valued at $7,530,015.12. The trade was a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock worth $6,386,550 in the last three months. Insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Cigna Group

Hedge funds and other institutional investors have recently made changes to their positions in the business. California State Teachers Retirement System boosted its stake in Cigna Group by 26,190.2% in the 2nd quarter. California State Teachers Retirement System now owns 106,647,359 shares of the health services provider's stock worth $29,400,544,000 after buying an additional 106,241,705 shares during the last quarter. BlackRock Inc. increased its stake in shares of Cigna Group by 3.7% during the 2nd quarter. BlackRock Inc. now owns 23,438,250 shares of the health services provider's stock valued at $6,461,457,000 after acquiring an additional 840,098 shares during the last quarter. State Street Corp lifted its holdings in shares of Cigna Group by 1.8% during the 4th quarter. State Street Corp now owns 12,339,250 shares of the health services provider's stock worth $3,396,132,000 after acquiring an additional 224,122 shares during the period. Dodge & Cox lifted its holdings in shares of Cigna Group by 19.7% during the 4th quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider's stock worth $3,065,681,000 after acquiring an additional 1,833,389 shares during the period. Finally, GQG Partners LLC boosted its position in shares of Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider's stock worth $2,136,699,000 after acquiring an additional 972,302 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company's stock.

Cigna Group Company Profile

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source